banner
Caspase activator PAC-1, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ060

Caspase activator PAC-1, Purity ≥98%

Synonym: 315183-21-2; PAC-1; PAC 1; Procaspase activating compound 1; 2-(4-Benzylpiperazin-1-yl)-N-((2-hydroxy-3-prop-2-enyl-phenyl)methylideneamino)acetamide; Caspase activator

  • CAS Number: 315183-21-2
  • Compound CID: 135421197
img
Product Size
10 mg; 25 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
PAC-1, soluble in DMSO and ethanol and insoluble in water, is an active small molecule compound that mediates the caspase signaling pathway. It targets procaspase-3.
Molecular Weight
392.5
Molecular Formula
C23H28N4O2
Targets
Procaspase-3: 0.22 μM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 75 mg/mL (191.09 mM); Water: Insoluble; Ethanol: 15 mg/mL (38.21 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
PAC-1 can be used to activate procaspase-3 to caspase-3, aiding in the study of apoptotic mechanisms.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.
0